dicer-substrate siRNA therapeutics
/ Novo Nordisk
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 08, 2011
Dicerna Pharmaceuticals to present at upcoming conferences
(Eon Businesswire)
- Dicerna Pharmaceuticals company developing novel therapeutics utilizing its proprietary Dicer substrate technology & DsiRNA molecules, today announced that the company will be presenting at the 16th annual meeting of the RNA Society, 2011 Boston Biotech CEO conference, SMI’s conference on RNAi, siRNA & miRNA & 2nd RNAi research & therapeutics conference in Jun & Jul
Anticipated presentations • Dyslipidemia
1 to 1
Of
1
Go to page
1